Bridging the gap between therapeutic research results and physician prescribing decisions: knowledge transfer, a prerequisite to knowledge translation

European Journal of Clinical Pharmacology
Jean-Pierre BoisselMargaret C Haugh

Abstract

A wide gap continues to exist between available therapeutic research results and physician's prescribing. Numerous explanations account for this gap, but one central reason is the difficulty in transferring comprehensive research information to practicing clinicians. This problem arises from information overload and the growing complexity of research findings. We propose a multistep process that can be used to develop systems to bridge this information/prescription gap. The steps include: comprehensively collecting and summarizing clinical trial reports, scoring and ranking these according to their level of evidence, exploring and synthesizing the data using meta-analyses, summarizing these results, representing them in an easily understandable form, and transmitting the overview findings to prescribers at the time they need them. This ambitious endeavor is needed to ensure that prescribers have access to pertinent research results for use in their prescription decisions. We demonstrate in this article that there are no theoretical or technical obstacles to make the proposed system workable.

References

Oct 3, 1992·BMJ : British Medical Journal·I ChalmersT C Chalmers
Nov 30, 1991·Lancet·J Wyatt
Apr 1, 1991·Annals of Internal Medicine·J A OsheroffR A Miller
Dec 1, 1989·Controlled Clinical Trials·J P Boissel
Dec 29, 1988·The New England Journal of Medicine·UNKNOWN Early Breast Cancer Trialists' Collaborative Group
Oct 1, 1985·Annals of Internal Medicine·D G CovellP R Manning
Oct 21, 1995·BMJ : British Medical Journal·T FaheyT J Peters
Oct 26, 1996·BMJ : British Medical Journal·R Smith
Jul 1, 1997·Computer Methods and Programs in Biomedicine·M CucheratM C Haugh
Dec 16, 1998·JAMA : the Journal of the American Medical Association·J P Boissel
Aug 6, 1999·BMJ : British Medical Journal·J W ElyE R Evans
Sep 24, 1999·Journal of the American Medical Informatics Association : JAMIA·L A Lenert, D J Cher
Feb 5, 2000·Computer Methods and Programs in Biomedicine·W N StrangJ P Boissel
Aug 11, 2000·BMJ : British Medical Journal·J W ElyP Z Stavri
Sep 1, 2000·BMJ : British Medical Journal·M FalshawR W Gray
Apr 13, 2001·Medical Reference Services Quarterly·R B Fitzpatrick
Mar 23, 2002·BMJ : British Medical Journal·John W ElyEric A Pifer
Jul 5, 2003·BMJ : British Medical Journal·Dave DavisMerrick Zwarenstein
Aug 14, 2003·Fundamental & Clinical Pharmacology·Jean-Pierre BoisselNigel Strang
May 19, 2004·Fundamental & Clinical Pharmacology·Nadine BossardJean-Pierre Boissel
Dec 29, 2005·Evidence-based Cardiovascular Medicine·J P Boissel

❮ Previous
Next ❯

Citations

Jan 13, 2009·European Journal of Clinical Pharmacology·U Hedegaard, P Damkier
May 10, 2013·European Journal of Clinical Pharmacology·Petra A Thürmann
Apr 16, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Thomas F HackLorna Weir
Jan 2, 2008·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Dante PappanoDomenick Roma
Aug 1, 2015·CPT: Pharmacometrics & Systems Pharmacology·J-P BoisselF-H Boissel
Sep 21, 2010·Journal of Biomedical Informatics·Samson W TuIda Sim
Jul 16, 2008·Clinical Pediatrics·Dante PappanoDomenick Roma
Mar 25, 2006·The Journal of Continuing Education in the Health Professions·Dave Davis
Nov 17, 2020·Frontiers in Cellular and Infection Microbiology·Shweta JaiswalPratyoosh Shukla

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.